SIRA® RFA Electrosurgical Device

About Innoblative Designs

Innoblative Designs is an emerging, privately-held medtech company focused on innovative surgical ablation technologies for oncology. Its core achievement is the SIRA® device, a radiofrequency ablation (RFA) tool cleared for use as an adjunct in breast-conserving surgery to provide localized margin control and reduce reoperation rates. The company is in the early commercial and clinical evidence generation stage, having secured critical regulatory approvals and a Category III CPT code, positioning it to address a significant need in breast cancer surgery. With a seasoned leadership team and multiple platform devices in development, Innoblative aims to expand its impact within soft tissue surgical oncology.

Therapeutic Areas